drugset
Drugs / Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine
last change Aug 2026 re-read 3 minutes ago

Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine

Vaccine

Developed for
hand, foot and mouth disease
Investigated by
Institute of Medical Biology, Chinese Academy of Medical Sciences · The Second Affiliated Hospital of Chongqing Medical University

Trials 1

today NCT07326878 · Ph 1
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07326878 Dec 2025 → Aug 2026 overdue hand, foot and mouth disease Institute of Medical Biology, Chinese Academy of Medical Sciences Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07326878 ↗
Modality Vaccine “Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine” NCT07326878 ↗